Pulsenmore Ltd. (TLV:PULS)
Israel
· Delayed Price · Currency is ILS · Price in ILA 313.30
-16.40 (-4.97%)
Apr 1, 2025, 4:06 PM IDT
Pulsenmore Market Cap
Pulsenmore has a market cap or net worth of 165.42 million as of April 1, 2025. Its market cap has decreased by -28.58% in one year.
Market Cap
165.42M
Enterprise Value
47.74M
Revenue
8.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
313.30
Market Cap Chart
Since June 15, 2021, Pulsenmore's market cap has decreased from 795.01M to 165.42M, a decrease of -79.19%. That is a compound annual growth rate of -33.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 165.42M | -34.26% |
| Dec 31, 2024 | 251.62M | -29.08% |
| Dec 31, 2023 | 354.81M | -4.28% |
| Dec 29, 2022 | 370.68M | -42.16% |
| Dec 30, 2021 | 640.93M | -19.38% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 63.85B |
| Danel (Adir Yeoshua) | 2.16B |
| Kamada | 1.46B |
| Bait Bakfar | 897.25M |
| Novolog (Pharm-Up 1966) | 845.44M |
| Ilex Medical | 741.81M |
| BrainsWay | 667.22M |
| SofWave Medical | 555.35M |